(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SLISUR

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

SLISUR

ST13

US500000079357946

Class

1, 5

Filing

79357946

Registration

7435304

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

35

Latest update

07/23/2026

Trademark type

Word

Nice classes

1, 5

Filing date

11/07/2022

Registration date

07/09/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/09/2024

Last transaction

07/23/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

16

Owner location

DE

Examiner

REINHART, MEGHAN M

Law office

L80

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Nucleic Acids to the Rescue GmbH
Gentechnologiestiftung -
B. W. (pessoa física)

Representatives

Nicholas D. Wells Legends Law Group, PLLC

Technical classification

Nice Classes

Class 1Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Chemical and biological substances in the nature of oligo- and poly-nucleotide arrays for scientific and medical research; reagents for scientific purposes; chemical and biological solvents for DNA and RNA extraction other than for medical or veterinary use; reagents for research in the field of diagnostics; chemical and biological substances in the nature of chemical and biological solvents for DNA and RNA extraction other than for medical or veterinary use; reagents for scientific or medical research use and reagents for scientific and research use

Class 5

Medical and veterinary preparations for the treatment of cancer and infectious diseases; Pharmaceuticalsnamely vaccines; chemical and biological substances in the nature of oligo- and poly-nucleotides andnucleotides for medical and veterinary treatment purposes and apatamers in the nature of nucleic acid antibodiesfor medical and veterinary purposes; reagents as part of medical and veterinary preparations; chemical and biological substances in the nature of oligo- and poly-nucleotides and nucleic acid antibodies all for medical and veterinary use; reagents for medical and veterinary use; agonists for medical and veterinary use; TLR agonists for medical and veterinary use; agonists as part of medical and veterinary preparations; TLR agonists as part of medical and veterinary preparations

Publications

History of USPTO decisions and trademark events.

35 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

07/23/2026

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

01/25/2025

XXSS

GENERIC MADRID TRANSACTION SENT TO IB

12/14/2024

XXCR

GENERIC MADRID TRANSACTION CREATED

12/14/2024

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

10/09/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

07/09/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

07/09/2024

CHLD

CHANGE OF OWNER RECEIVED FROM IB

06/21/2024

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

06/17/2024

CHLD

CHANGE OF OWNER RECEIVED FROM IB

06/14/2024

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

05/15/2024

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

05/15/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/23/2024

GPNX

NOTIFICATION PROCESSED BY IB

04/23/2024

PUBO

PUBLISHED FOR OPPOSITION

04/23/2024

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

04/03/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/03/2024

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

04/03/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/21/2024

XAEC

EXAMINER'S AMENDMENT ENTERED

03/21/2024

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

03/21/2024

GNEA

EXAMINERS AMENDMENT E-MAILED

03/21/2024

CNEA

EXAMINERS AMENDMENT -WRITTEN

03/21/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/07/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/07/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/07/2024

RFNT

REFUSAL PROCESSED BY IB

10/10/2023

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

09/20/2023

RFRR

REFUSAL PROCESSED BY MPU

09/20/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

09/01/2023

CNRT

NON-FINAL ACTION WRITTEN

08/31/2023

DOCK

ASSIGNED TO EXAMINER

08/22/2023

MAFR

APPLICATION FILING RECEIPT MAILED

12/23/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/19/2022

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

12/17/2022

Continuous trademark protection

Get notified about every new filing that threatens SLISUR or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.